dihexa cancer risk hgf c-met targets neurotrophic factors like BDNF and NGF, which drive brain repair. By activating the receptor, it helps cells take in nutrients and rebuild—especially in cases where recovery is Targeting cancer-associated fibroblast-activated HGF/c-MET pathway
Targeting cancer associated fibroblast activated HGF c MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity ScienceDirect HGF and MET: From Brain Development to Neurological Disorders PMC dihexa hgf c met cancer risk HGF c MET pathway in cancer: from molecular characterization to clinical evidence Targeted Inhibition of Hepatocyte Growth Recent Progress and Advances in HGF MET Targeted Therapeutic Agents for Cancer Treatment
Pay in 4 interest-free payments of $6.31 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12



